 modal therapi advanc non-smal cell lung carcinoma multi-mod treatment cisplatin chemotherapi extern beam radiat patient advanc stage iii non-smal cell lung carcinoma regimen preoper fashion cycl patient resect cur intent cycl remaind patient clinic respons rate entir group overal local control rate median surviv month median follow-up live patient month actuari surviv disease-fre surviv rate histolog complet respons surviv actuari surviv disease-fre surviv rate resect patient complet histolog respond disease-fre surviv pattern first recurr histolog presenc lymph node subset patient actuari surviv disease-fre surviv rate inoper patient cycl treatment local control major patient stage iiib diseas mountain intern system oper local recurr surviv concomit treatment regimen feasibl major toxic leukopenia nausea vomit